Table 5.
Triglycerides adverse change (AC) rates. Interactions with baseline characteristics
| Control | Exercise | Interaction p-value | |
|---|---|---|---|
|
| |||
| Agea: AC | 55 (41–64) | 55 (45–63) | 0.71 |
| Non-AC | 53 (40–65) | 54 (44–64) | |
|
| |||
| Gender: | 0.16 | ||
| AC female | 11.4% | 12.0% | |
| AC male | 19.0% | 11.0% | |
|
| |||
| Race/ethnicity: | 0.30 | ||
| AC Caucasian | 14.8% | 12.0% | |
| AC Afr-Amer | 8.2% | 11.4% | |
| AC Hispanic/other | 18.2% | 8.6% | |
|
| |||
| BMI: AC | 30 (26–36) | 30 (26–36) | 0.89 |
| Non-AC | 30 (26–36) | 30 (25–36) | |
|
| |||
| Peak VO2: AC | 21.2 (13.4–31.8) | 17.2 (13.2–36.1) | 0.68 |
| Non-AC | 20.7 (13.0–34.2) | 19.5 (12.8–33.2) | |
Continuous variables are reported as: median (10th percentile, 90th percentile)